Javascript must be enabled to continue!
Developing guidelines for research institutions
View through CrossRef
As introduced in Chapter 1, in this thesis, I developed guidelines to research institutions on how to foster research integrity. I did this by exploring how research institutions can develop policies to foster, and raise awareness about, research integrity.
In Section 1 of the thesis, my goal was to set the research agenda by investigating current practices of research integrity promotion at research institutions (the descriptive step), and exploring which topics should be addressed in institutional research integrity policies (the normative step). I addressed the descriptive step of looking at current practices, through a scoping review (Chapter 2). In this chapter, I found that while there are already many institutional practices for research integrity promotion globally, most of them focus on researchers’, rather than institutions’ responsibilities for fostering research integrity. In Chapter 3, I tackled the normative question of which topics should be included in institutional research integrity policies. Using a Delphi study that included a number of research policy experts and research leaders, I developed a comprehensive list of 12 topics that research institutions should address to foster research integrity.
Section 2 of the thesis focused on developing guidelines for research institutions on research integrity. I specifically zoomed in further into ‘Research integrity education and training’ as the topic of the guidelines here. The first step to developing the guidelines was to examine researchers’ and other research stakeholders’ views and preferences regarding how research institutions can develop and implement better research integrity education and training policies (Chapter 4). Using focus groups, I found that researchers and other research stakeholders support the provision of continuous research integrity education which targets all researchers (across ranks), and other institutional stakeholders (such as research integrity officers and institutional leaders).
Next, I proceeded to co-creating institutional guidelines on research integrity education and training together with users. In Chapter 5, I discussed how research integrity guidelines can be jointly developed with users using co-creation methods – methods engaging participants in interactive exercises aimed at jointly developing user centered outputs. The resulting RI education and training guidelines are presented in detail Chapter 6. The guidelines address the research integrity education of a) bachelor, master and PhD students; b) post-doctorate and senior researchers; c) other research integrity stakeholders; as well as d) continuous research integrity education. In the guidelines, I recommend the implementation of mandatory research integrity training (for all academic ranks); follow-up refresher training; informal discussions about research integrity; appropriate rewards and incentives for active participation in research education; and evaluation of research integrity educational events across target groups.
In Section 3 of this dissertation, I reflected on an implementation concern regarding the guidelines developed. I explored the question of how research institutions can combine the implementation of research integrity rules with fostering researchers’ commitment to engage in responsible research practices (Chapter 7). I argued that institutions can use and combine market (governance through incentives), bureaucracy (governance through rules) and network (cooperative governance) mechanisms to foster research integrity. Using Habermas’ Theory of Communicative Action, I discussed that institutions can use bureaucratic and market mechanisms to foster research integrity (such as rules and incentives, respectively), as long as these are rooted in network processes (e.g. involvement of stakeholders in the development and improvement of rules or incentives).
In Chapter 8, I concluded that: 1) the framing of research integrity matters for institutional policies; 2) research integrity guidelines should be tailored to the local context at hand; 3) it is important to be aware of and countervail the danger of creating a box-checking mentality when implementing institutional research integrity policies; and 4) research integrity is a journey.
Title: Developing guidelines for research institutions
Description:
As introduced in Chapter 1, in this thesis, I developed guidelines to research institutions on how to foster research integrity.
I did this by exploring how research institutions can develop policies to foster, and raise awareness about, research integrity.
In Section 1 of the thesis, my goal was to set the research agenda by investigating current practices of research integrity promotion at research institutions (the descriptive step), and exploring which topics should be addressed in institutional research integrity policies (the normative step).
I addressed the descriptive step of looking at current practices, through a scoping review (Chapter 2).
In this chapter, I found that while there are already many institutional practices for research integrity promotion globally, most of them focus on researchers’, rather than institutions’ responsibilities for fostering research integrity.
In Chapter 3, I tackled the normative question of which topics should be included in institutional research integrity policies.
Using a Delphi study that included a number of research policy experts and research leaders, I developed a comprehensive list of 12 topics that research institutions should address to foster research integrity.
Section 2 of the thesis focused on developing guidelines for research institutions on research integrity.
I specifically zoomed in further into ‘Research integrity education and training’ as the topic of the guidelines here.
The first step to developing the guidelines was to examine researchers’ and other research stakeholders’ views and preferences regarding how research institutions can develop and implement better research integrity education and training policies (Chapter 4).
Using focus groups, I found that researchers and other research stakeholders support the provision of continuous research integrity education which targets all researchers (across ranks), and other institutional stakeholders (such as research integrity officers and institutional leaders).
Next, I proceeded to co-creating institutional guidelines on research integrity education and training together with users.
In Chapter 5, I discussed how research integrity guidelines can be jointly developed with users using co-creation methods – methods engaging participants in interactive exercises aimed at jointly developing user centered outputs.
The resulting RI education and training guidelines are presented in detail Chapter 6.
The guidelines address the research integrity education of a) bachelor, master and PhD students; b) post-doctorate and senior researchers; c) other research integrity stakeholders; as well as d) continuous research integrity education.
In the guidelines, I recommend the implementation of mandatory research integrity training (for all academic ranks); follow-up refresher training; informal discussions about research integrity; appropriate rewards and incentives for active participation in research education; and evaluation of research integrity educational events across target groups.
In Section 3 of this dissertation, I reflected on an implementation concern regarding the guidelines developed.
I explored the question of how research institutions can combine the implementation of research integrity rules with fostering researchers’ commitment to engage in responsible research practices (Chapter 7).
I argued that institutions can use and combine market (governance through incentives), bureaucracy (governance through rules) and network (cooperative governance) mechanisms to foster research integrity.
Using Habermas’ Theory of Communicative Action, I discussed that institutions can use bureaucratic and market mechanisms to foster research integrity (such as rules and incentives, respectively), as long as these are rooted in network processes (e.
g.
involvement of stakeholders in the development and improvement of rules or incentives).
In Chapter 8, I concluded that: 1) the framing of research integrity matters for institutional policies; 2) research integrity guidelines should be tailored to the local context at hand; 3) it is important to be aware of and countervail the danger of creating a box-checking mentality when implementing institutional research integrity policies; and 4) research integrity is a journey.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Gender Differences in Authorship and Quality of Anesthesia Clinical Practice Guidelines From 2016 to 2020 Using the Appraisal of Guidelines for Research and Evaluation II Instrument
Gender Differences in Authorship and Quality of Anesthesia Clinical Practice Guidelines From 2016 to 2020 Using the Appraisal of Guidelines for Research and Evaluation II Instrument
INTRODUCTION:
Women continue to be underrepresented in academic anesthesiology. This study assessed guidelines in anesthesia journals over the past 5 years, eva...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Associations of Meeting 24-hour Movement Guidelines with Stress and Self-rated Health among Adults: Is Meeting more Guidelines Associated with Greater Benefits?
Associations of Meeting 24-hour Movement Guidelines with Stress and Self-rated Health among Adults: Is Meeting more Guidelines Associated with Greater Benefits?
Abstract
Background: Several countries have recently issued 24-hour movement guidelines for adults. From a public health perspective, it is important to explore the health ...
Quality Guidelines for Corona Virus Disease 2019 with AGREE II Instrument.
Quality Guidelines for Corona Virus Disease 2019 with AGREE II Instrument.
Objective: Numerous clinical practice guidelines (CPGs) for the corona
virus disease 2019 (COVID-19) have been developed since its outbreak. To
date, however, the methodological qu...

